Feng JH - Search Results

1

The intrapleural administration with thymic peptides in malignant pleural effusion: A clusteredsystematicreview and meta-analysis.

Wang CQ, Shen YS, Chen XF, Jiang H, Yang XM, Fan TY, Li SG, Yang P, Zhan L, Chen R, Feng JH, Xiao X, Xiao Z. Wang CQ, et al. Among authors: feng jh. Int Immunopharmacol. 2022 Jun;107:108688. doi: 10.1016/j.intimp.2022.108688. Epub 2022 Mar 12. Int Immunopharmacol. 2022. PMID: 35293322

2

Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials.

Xiao Z, Wang C, Chen L, Tang X, Li L, Li N, Li J, Gong Q, Tang F, Feng J, Li X. Xiao Z, et al. Oncotarget. 2017 Jan 3;8(1):1329-1342. doi: 10.18632/oncotarget.13617. Oncotarget. 2017. PMID: 27901493 Free PMC article.

3

Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials.

Xiao Z, Wang C, Zhou R, Hu S, Yi N, Feng J, Zhou M, Liu S, Chen L, Ding J, Gong Q, Tang F, Li X. Xiao Z, et al. Complement Ther Med. 2018 Apr;37:50-60. doi: 10.1016/j.ctim.2018.01.011. Epub 2018 Jan 31. Complement Ther Med. 2018. PMID: 29609937 Review.

4

Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.

Xiao Z, Wang CQ, Zhou MH, Li NN, Liu SY, He YJ, Wang YZ, Feng JH, Yao XS, Chen L, Ma B, Yu S, Zeng XT, Li CW, Ding J. Xiao Z, et al. Among authors: feng jh. Int Immunopharmacol. 2018 Aug;61:363-375. doi: 10.1016/j.intimp.2018.06.012. Epub 2018 Jun 23. Int Immunopharmacol. 2018. PMID: 29945024

5

Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials.

Xiao Z, Wang C, Li L, Tang X, Li N, Li J, Chen L, Gong Q, Tang F, Feng J, Li X. Xiao Z, et al. Evid Based Complement Alternat Med. 2018 Jun 11;2018:7918258. doi: 10.1155/2018/7918258. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 29991956 Free PMC article.

6

Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials.

Xiao Z, Wang C, Tan Z, Hu S, Chen Y, Zhou M, Feng J, Liu S, Chen L, Ding J, Gong Q, Tang F, Liu H, Li X. Xiao Z, et al. J Clin Pharm Ther. 2019 Feb;44(1):23-38. doi: 10.1111/jcpt.12761. Epub 2018 Sep 19. J Clin Pharm Ther. 2019. PMID: 30229971

7

Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.

Xiao Z, Wang C, Zhou M, Hu S, Jiang Y, Huang X, Li N, Feng J, Tang F, Chen X, Ding J, Chen L, Wang Y, Li X. Xiao Z, et al. J Ethnopharmacol. 2019 Jan 10;228:110-122. doi: 10.1016/j.jep.2018.09.024. Epub 2018 Sep 20. J Ethnopharmacol. 2019. PMID: 30243827

8

Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.

Xiao Z, Wang CQ, Feng JH, Zhou MH, Wang YZ, Li NN, Sun YP, Liu SY, Yao XS, Li CW, Ma B, Ding J, Chen L. Xiao Z, et al. Among authors: feng jh. Cytotherapy. 2019 Feb;21(2):125-147. doi: 10.1016/j.jcyt.2018.10.011. Epub 2018 Dec 14. Cytotherapy. 2019. PMID: 30554868

9

The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.

Xiao Z, Wang CQ, Zhou MH, Li NN, Sun YP, Wang YZ, Liu SY, Yu HS, Li CW, Zeng XT, Chen L, Yao XS, Feng JH. Xiao Z, et al. Among authors: feng jh. J Immunol Res. 2018 Dec 13;2018:9081938. doi: 10.1155/2018/9081938. eCollection 2018. J Immunol Res. 2018. PMID: 30648123 Free PMC article.

10

Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines.

Zeng FL, Xiao Z, Wang CQ, Jiang Y, Shan JL, Hu SS, Huang XR, Tang YH, Yao XS, Zhang T, Zeng XT, Feng JH, Xiao X. Zeng FL, et al. Among authors: feng jh. Int Immunopharmacol. 2019 Oct;75:105747. doi: 10.1016/j.intimp.2019.105747. Epub 2019 Jul 18. Int Immunopharmacol. 2019. PMID: 31326719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page